AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitabet M 50mg/1000mg Tablet

Prescription Icon
Prescription Required

Marketer

East West Pharma

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitabet M 50mg/1000mg Tablet

DiabetaComb 50mg/1000mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lessening the risk of cardiovascular events. DiabetaComb may be used independently or with other diabetes treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood sugar readings, and concurrent medications. Consuming the tablets with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under medical supervision. Adherence to your physician's dietary and exercise plan is crucial. Lifestyle significantly impacts diabetes control. Common side effects include nausea, diarrhea, vomiting, dyspepsia, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; learn to recognize and manage this complication. This medication isn't universally suitable. Inform your doctor of any history of cardiac, hepatic, or renal disease, pancreatic issues, or significant alcohol consumption before commencing treatment. Pregnant or lactating individuals should consult their doctor. Interactions with other medications are possible; disclose all current medications to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your physician will monitor kidney function and blood glucose levels throughout treatment.

Uses of Sitabet M 50mg/1000mg Tablet

Managing type 2 diabetes

Major Benefits of Sitabet M 50mg/1000mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 50mg/1000mg Sitabet M Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Sitabet M 50mg/1000mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitabet M 50mg/1000mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Sitabet M 50mg/1000mg Tablet should be administered with a meal.

How Sitabet M 50mg/1000mg Tablet works:

Sitagliptin/metformin 50mg/1000mg tablets (Sitabet M) combine two distinct agents to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual-action approach leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Sitabet M 50mg/1000mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitabet M 50mg/1000mg tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Sitabet M 50mg/1000mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitabet M 50mg/1000mg tablets cautiously, potentially requiring dosage modification. Consult a physician. Sitabet M 50mg/1000mg tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

The use of Sitabet M 50mg/1000mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitabet M 50mg/1000mg Tablet :

Should you forget a Sitabet M 50mg/1000mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Sitabet M 50mg/1000mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitabet M 50mg/1000mg Tablet

Sitabet M 50mg/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when coupled with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Prolonged use of Sitabet M 50mg/1000mg Tablet can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitabet M 50mg/1000mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sitabet M 50mg/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitabet M 50mg/1000mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitabet M 50mg/1000mg) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitabet M and seek immediate medical attention.
Sitabet M 50mg/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitabet M 50mg/1000mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with allergies to Sitabet M 50mg/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining alcohol and Sitabet M 50mg/1000mg tablets is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitabet M 50mg/1000mg) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitabet M and seek immediate medical attention.
Prolonged use of Sitabet M 50mg/1000mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitabet M 50mg/1000mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitabet M 50mg/1000mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitabet M 50mg/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitabet M 50mg/1000mg Tablet with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (Sitabet M 50mg/1000mg) can cause lactic acidosis, a serious, albeit rare, medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This risk is heightened in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Sitabet M and seek immediate medical attention.
Prolonged use of Sitabet M 50mg/1000mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitabet M 50mg/1000mg Tab...
169
MRP 197
13% off